Up next

Autoplay

SOLO-1: Frontline Olaparib Maintenance Therapy in Ovarian Cancer

5 Views • 07/08/23
Share
Embed
administrator
administrator
Subscribers
0

Experts review the SOLO-1 trial and olaparib’s role as maintenance therapy following the frontline management of ovarian cancer.

Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay